Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06581835 · ClinicalTrials.gov registry record
Accuracy Performance Verification of the INVOS™ PM7100 System in Adults
A clinical trial of Oxygen Saturation, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 42
- Enrollment target
- 1
- Study location
NCT06581835 is a study of Oxygen Saturation that has completed, run by Medtronic - MITG. The registered enrollment target is 42 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06581835, a study of Oxygen Saturation, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, observational, post-market, verification study to ensure compliance to the ISO 80601-2-85:2021 standard
Conditions Studied
Interventions
- DEVICE Observational
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2025-07-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06581835
The ClinicalTrials.gov registry entry for NCT06581835 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Oxygen Saturation appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT06581835 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06581835 about?
NCT06581835 is a clinical study titled "Accuracy Performance Verification of the INVOS™ PM7100 System in Adults". Prospective, observational, post-market, verification study to ensure compliance to the ISO 80601-2-85:2021 standard
What is the current status of trial NCT06581835?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2024-10-21. Estimated completion is 2025-07-22.
What conditions does trial NCT06581835 study?
This clinical trial studies the following conditions: Oxygen Saturation.
What interventions are being tested in trial NCT06581835?
The interventions under investigation include: Observational (DEVICE).
Who is sponsoring clinical trial NCT06581835?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06581835 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oxygen Saturation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.